Search - tctmd.com

Displaying 161 - 180 of 307

Sort: Relevancy | Date

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2023

Shelley Wood

July 03, 2023

News Opinion CV Team Dispatch

July 2023 News Roundup

L.A. McKeown

July 01, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Daily News

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Caitlin E. Cox

June 30, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

Online Emotion Trumped CPR Education After Damar Hamlin’s Cardiac Arrest

L.A. McKeown

June 27, 2023

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

Todd Neale

June 26, 2023

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

Caitlin E. Cox

June 26, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Caitlin E. Cox

June 13, 2023

Presentation TVT 2023

What do the New Trials Need to Show In Light of PROTECTED-TAVR

Presenter: Amit Vora

June 09, 2023

Advertisement

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

LDL Control Remains Poor in CAD Patients: NHANES

TCTMD’s Top 10 Most Popular Stories for June 2023

July 2023 News Roundup

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Online Emotion Trumped CPR Education After Damar Hamlin’s Cardiac Arrest

Method to Overcome CAC Score Variability Hones Risk Stratification

Wintertime Brings Increased IHCA Risk, US Data Show

AHA Scientific Statement Addresses Health Disparities in PAD

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

FDA Approves Colchicine for Decreasing CV Events

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

What do the New Trials Need to Show In Light of PROTECTED-TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content